Studies of chloroquine and hydroxychloroquine with or without azithromycin have major limitations that have prevented the medical community from adopting these treatments without further studies. Oseltamivir does not inhibit SARS-CoV-2 in vitro and has no known role in the treatment of COVID-19.
Utafiti kuhusu dawa ya chloroquine na hydroxychloroquine iwe au isiwe na chembe cha azithromycin una upungufu mkubwa ambao umewazuia wataalamu wa matibabu kukumbatia matibabu haya bila utafiti zaidi kufanywa. Oseltamivir haizuii SARS-CoV-2 katika utungishaji na haina jukumu linalofahamika katika matibabu ya COVID-19.